Brucella as a potential agent of bioterrorism

Recent Patents on Anti-Infective Drug Discovery

Volumn 8, Issue 1, 2013, Pages 27-33

  Doganay, Gizem D ^a   Doganay, Mehmet ^b  

^a ISTANBUL TECHNICAL UNIVERSITY   (Turkey)

^b ERCIYES UNIVERSITY   (Turkey)

Author keywords

Biotechnology; Bioterrorism; Brucellosis; Decontamination; Diagnosis; Patents

Indexed keywords

BRUCELLA VACCINE; CHLORINE; COTRIMOXAZOLE; DOXYCYCLINE; GENTAMICIN; HYDROGEN PEROXIDE; PERACETIC ACID; RIFAMPICIN; STREPTOMYCIN;

ANTIBIOTIC SENSITIVITY; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; BACTERIUM CULTURE; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; BIOLOGICAL WARFARE; BIOSENSOR; BLOOD ANALYSIS; BRUCELLA; BRUCELLA ABORTUS; BRUCELLA CANIS; BRUCELLA INOPINATA; BRUCELLA MELITENSIS; BRUCELLA MICROTI; BRUCELLA NEOTOMAE; BRUCELLA PINNIPEDIALIS; BRUCELLA SUIS; BRUCELLOSIS; DISINFECTION; DRUG RESEARCH; ELECTROPHORESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; FOOD CONTAMINATION; HUMAN; IMMUNOASSAY; INFRARED SPECTROSCOPY; INHALATION; LABORATORY TEST; MORTALITY; POLYMERASE CHAIN REACTION; POST EXPOSURE PROPHYLAXIS; POTENTIOMETRY; PRIORITY JOURNAL; REVIEW; VARIABLE NUMBER OF TANDEM REPEAT;

ANIMALS; BIOSENSING TECHNIQUES; BIOTECHNOLOGY; BIOTERRORISM; BRUCELLA; BRUCELLOSIS; HUMANS; PATENTS AS TOPIC; ZOONOSES;

EID: 84875609445     PISSN: 1574891X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157489113805290782     Document Type: Review

References (60)

1. Cirincione J, Wolfsthal J, Rajkumar M. Deadly arsenal: Nuclear, biological and chemical threat. Second edition. Carnegie Endowment for International Peace: Washington, 2005.
2. Valderas MW, Roop RM. Brucella and Bioterrorism. In: Anderson B, Friedman H, Bendinelli M. Microorganism and Bioterrorism. Florida: Springer 2006:139-53.
3. Center for Disease Control and Prevention. Bioterrorism agents/Diseases by Category. Available at: http://emergency.cdc.gov/agent/agentlist-category.asp (Accessed on: January 11, 2012).
4. National Institute of Allergy and Infectious Diseases. Biodefense and Emerging Infectious Diseases. Available at: htt://www.niaid.nih.gov/topics/BiodefenseRelated/Biodefense/Page s/CatAaspx (Accessed on: January 11, 2012).
5. Pappas G, Papadimitriou P, Akritidis N, Christou L, Tsianos EV. The new global map of human brucellosis. Lancet Infect Dis 2006; 6: 91-9.
6. James Martin Center for Nonproliferation Studies. Chronology of CBW incidents targeting agriculture 1915-2008. Available at: http://cns.miis.edu/cbw/agchron.htm (Accessed on: February 24, 2012).
7. Jernigan DB, Raghunathan PL, Bell BP, Brechner R, Bresnitz EA, Butler JC, et al. Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings. Emerg Infect Dis 2002; 8:1019-28.
8. Pappas G, Panagopoulou P, Akritidis N. Reclassifiying bioterrorism risk: Are we preparing for the proper pathogen? J Infect Public Health 2009; 2: 55-61.
9. Euzéby JP. List of Prokaryotic names with Standing in Nomenclature-Genus Brucella. Available at: http://www.bacterio.cict.fr/b/brucella.html (Accessed on: March 21, 2012).
10. Purcell BK, Hoover DL, Friedlander AM. Brucellosis. In: Lenhart MK, Lounesbury DE, Martin JM 8eds). Medical Aspect of Biological Warfare, Textbook of Military Medicine, Washington, DC: Office of The Surgeon General, US Army, 2007: 186-198.
11. Corbel MJ. Brucellosis: An overview. Emerg Infect Dis 1997; 3:213-221.
12. Doganay M, Aygen B. Human brucellosis: An overview. Int J Infect Dis 2003;7:173-82.
13. Corbel MJ, Alton GG, Ariza J, Banai M, Cosivi O, Diaz R, et al. Brucellosis in humans and animals. World Health Organization: Geneva, 2006.
14. Pappas G, Panagopoulou P, Christou L, Akritidis N. Brucella as a biological weapon. Cell Mol Life Sci 2006; 63: 2229-36.
15. Kaufmann AF, Meltzer MI, Schmid GP. The economic impact of a bioterrorist attack: Are perevention and postattack intervention program justifiable? Emerg Infect Dis 1997; 3:83-94.
16. Gyles C. Agroterrorism. Can Vet J 2010; 51: 347-8.
17. Goldfroid J, Scholz HC, Barbier T, Nicolas, Wattiau P, Fretin D, et al. Brucellosis at the animal/ecosystem/human interface at the beginning of 21th century. Prevent Vet Med 2011; 102: 118-31.
18. Godfroid J, Cloeckaert A, Liautard JP, Kohler S, Fretin D, Walravens K, et al. From the discovery of Malta fever's agent to the discovery of marine mammals reservoir, brucellosis has continuously been a re-emerging zoonosis. Vet Res 2005; 36: 313-26.
19. Robinson-Dunn B. The microbiology laboratory's role in response to bioterrorism. Arch Pathol Lab Med 2002; 126: 291-4.
20. Yagupsky P, Baron EJ. Laboratory exposure to Brucellae and implications for bioterrorism. Emerg Infect Dis 2005; 11: 1180-5.
21. Falenski A, Mayer-Scholl A, Filter M, Gölner C, Appel B, Nöckler K. Survival of Brucella spp. in mineral water, milk and yogurt. Int J Food Microbiol 2011; 145: 326-30.
22. Cannons A, Amuso P, Anderson B. Biotechnology and the public health response to bioterrorism. In: Anderson B, Friedman H, Bendinelli M. Microorganism and bioterrorism. Florida: Springer 2006:1-13.
23. Kaspar CW, Tartera C. Methods for detecting microbial pathogens in food and water. Methods Microbiol 1990; 22: 497-530.
24. Hobson NS, Tothill I, Turner APF. Microbial Detection. Biosens Bioelectron 1996; 11(5): 455-77.
25. Dauphin LA, Hutchins RJ, Bost LA, Bowen MD. Evaluation of automated and manual commercial DNA extraction methods for recovery of Brucella DNA from suspensions and spiked swabs. J Clin Microbiol 2009; 47: 3920-6.
26. Greenfield RA, Drevets DA, Machado LJ, Voskuhl GW, Cornea P, Bronze MS. Bacterial pathogens as biological weapons and agents of bioterrorism. Am J Med Sci 2002; 323: 299-315.
27. Verger JM, Grimont F, Grimont PAD, Grayon M. Brucella, a monospecific genus as shown by deoxyribonucleic acid hybridization. Int J Syst Bacteriol 1985; 35: 292-5.
28. Rees RK, Graves M, Caton N, Ely JM, Probert WS. Single tube identification and strain typing of Brucella melitensis by multiplex PCR. J Microbiol Methods 2009; 78: 66-70. doi: 10.1016/j.mimet.2009.04.010.
29. Lindstedt BA. Multiple-locus variable number tandem repeats analysis for genetic fingerprinting of pathogenic bacteria. Electrophoresis 2005; 26: 2567-82.
30. Schmoock G, Ehricht R, Melzer F, Elschner M, Tomaso H, Neubauer H, et al. Development of a diagnostic multiplex polymerase chain reaction microarray assay to detect and differentiate Brucella spp. Diagn Micr Infec Dis 71(4): 341-53.
31. Lane DJ, Pace B, Olsen GJ, Stahl DA, Sogin ML, Pace NR. Rapid determination of 16S ribosomal RNA sequences for phylogenetic analyses (reverse transcriptase/dideoxynudeotide). Proc Natl Acad Sci USA 1985; 82: 6955-9.
32. Wilson KH, Blitchington RB, Greene RC. Amplification of bacterial 16s ribosomal DNA with polymerase chain reaction. J Clin Microbiol 1990; 28: 942-1946.
33. Ruppitsch W, Stöger A, Indra A, Grif K, Schabereiter-Gurtner C, Hirschl A, et al. Suitability of partial 16S ribosomal RNA gene se quence analysis for the identification of dangerous bacterial pathogens. J Appl Microbiol 2007; 102: 852-9.
34. Miguel-Gomez MA, Bratos-Perez MA, Martin-Gil FJ, Duenas-Diez A, Martin-Rodriguez JF, et al. Identification of species of Brucella using Fourier transform infrared spectroscopy. J Microbiol Methods 2003; 55(1):121-31.
35. Ivnitski D, Abdel-hamid I, Atanasov P and Wilkins E. Biosensors for detection of pathogenic bacteria. Biosens Bioelectron 1999; 14: 599-624.
36. Goepel W. Chemical sensing, molecular electronics, and nanotechnology: interface technologies down to the molecular scale. Sensors Actuators B 1991; 4:7-21.
37. Sethi, RS. Transducer aspects of biosensors. Biosens Bioelectron 1994; 9: 243-64.
38. Goepel W, Heiduschka P. Interface analysis in biosensor design. Biosens Bioelectron 1995; 10: 853-83.
39. Lee WE, Hall JG, Thompson HG. Fluorescence immunofiltration assay of Brucella melitensis. In: Alberta R. Defence Research Establishment Suffield. Suffield Memorandum No.1407, 1995.
40. Silva M, Cruz H, Rossetti O, Arese A, Oliva A. Development of an optical immunosensor based on the fluorescent of cyanini-5 for veterinarian diagnostics. Biotechnol Lett 2004; 26: 993-7.
41. Edelstein RL, Tamanaha CR, Sheehan PE, Miller MM, Baselt DR, Whitman LJ, et al. The BARC biosensor applied to the detection of biological warfare agents. Biosens Bioelectron 2000; 14: 805-13.
42. Lee WE, Thompson HG, Hall JG, Bader DE. Rapid detection and identification of biological and chemical agets by immunoassay, gene probe assay and enzyme inhibition using a silicon-based biosensor. Biosens Bioelectron 2000; 14: 795-804.
43. Moorchung LCN, Sharma BAK, Mehta LGS. Bioshock: Biotecnology and bioterrorism. MJAFI 2009; 65:359-62.
44. Edward, A., Scott, A.D., Zachary, P., Pamela, M., Alec, A. Surface sampler for bioterrorism particl detection. US2010313686A1 (2010).
45. Srinagesh, S., Sulatha, D. Method and apparatus for low quantity detection of bioparticles in small sample volumes. WO2007044029 (2007).
46. Seung-Hun, H., Hyun, P.T., Tae-Hyun, K., Hun L.S. Olfactory recepror-functionalized transistors for highly selectie bioelectronic nose and biosensor using the same. US2011059544 (2011).
47. Peter, L., Thomas, S., Joseph, B. Effective monitoring system or anthrax, smallpox or other pathogens. US2009162891 (2009).
48. Sampath, R., Hall, T.A., Ecker, D.J., Blyn, L Compositions for use in identification of bacteria. US7956175 (2011).
49. Grote, G. Test kit for detecting Brucella species, potential biological warfare agents, in the environment, comprises primers for specific amplication, optionally also hybridization probe. DE10261468A1 (2004).
50. Ecker, D.J., Griffey, R.H., Sampath, R., Hofstadler, S., McNeil, J. Method for rapid detection and identification of bioagents. US8017358B2 (2011).
51. Ecker, D.J., Griffey, R.H., Sampath, R., Hofstadler, S., McNeil, J., Crooke, S.T., Blyn, L., Ranken, R., Hall, T.A. Methods for rapid identification of pathogens in humans and animals. US8071309 (2011).
52. Marc, L. Methods of detection one or more bioterrorism target agents. Us2010279278A1 (2010).
53. Gardner, C.W., Maier, J.S., Nelson, M.P., Schweitzer, R.C., Treado, P.J., Vanni, G.S., Wolfe, J. Method for detection of pathogenic microorganisms. US7113275B2 (2006).
54. Alocilja E.C., Pal, S., Setterington, E. Electrically-active ferromagnetic particle conductimetric biosensor test kit. US2008314766A1 (2008).
55. Wang. J., Sun, X., Yang, Y., Wen, H., Liu, H., Hu, K. genetic liquid phase chip for joint detection of five drastic pathogenic bacteria and detection method thereof. CN101560557A (2009).
56. Leggiardo RJ. Laboratory-acquired brucellosis-Indiana and Minnesota, 2006. MMMR 2008; 57(02): 39-42.
57. Bossi P, Tegnell A, Baka A, Van Loock F, Hendriks J, Werner A, et al. Bichat guidelines for the clinical management of brucellosis and bioterrorism-related brucellosis. Euro Surveill 2004; 9(12).
58. Kaiser, N.E., Newman, J.L., Heisig, C., Kaiser, H.J., K., Tienes, B.M., Klein, D.A., Linder, J.S., Frey, K.T. Low odor, hard surface sporocides and chemical decontaminants. MX2011008257A (2011).
59. Richardson, D.E., Denevan, D., Ramdon, D.C. On-demand portable chlorine dioxide generator. US2011262342A1 (2011).
60. Gutsol, A., Fridman, A., Gallagher, M.J., Vasilets, V., Blank, K. Method and device for air disinfection and sterilazition. WO2008097347A2 (2008).